MARKETWIRE.NET

Decode Your Next Market Move

Global Industry Analysts, Inc. (GIA) launches comprehensive analysis of industry segments, market trends, growth drivers, market share, size and demand forecasts on the global Cell Harvesting market. Market segmentation includes Application (Peripheral Blood, Bone Marrow, Umbilical Cord, Adipose Tissue, and Other Applications).

Find Out More About Regions, Brands, Dominant, Active & Niche Companies Covered in the Report

24 November 4:22 a.m., Silicon Valley, California - According to the new market research report, the global market for cell harvesting is projected to grow at a CAGR of 7.3% reach US$381.4 million by 2027, driven by increasing investments in clinical, cell-based and regenerative medicine research. The global Cell Harvesting market will be reset to a new normal which going forwards in a post COVID-19 era will be continuously redefined and redesigned. Peripheral Blood, one of the segments analyzed and sized in this study, is forecast to grow at over 6.9% and reach a market size of US$202.2 million by the end of the analysis period. The United States is forecast to readjust to a 7.3% CAGR. Within Europe, the worst affected by the pandemic, Germany will reach a market size of US$36.8 million growing at a CAGR% of 6.6% over the next couple of years. In addition, over US$29.4 million worth of projected demand in the region will come from Rest of European markets. In Japan, the Peripheral Blood segment will reach a market size of US$17.6 million by the close of the analysis period. Facing a global backlash over the coronavirus outbreak and spread, China the world's second largest economy faces economic and geopolitical challenges including economic distancing which can likely put China's monopoly of global supply chains in crisis. The Peripheral Blood segment in this country against this backdrop will grow at a CAGR of 9.8% over the next couple of years to create an addressable market opportunity worth US$17 million by the year 2027.

The global cell harvesting market is anticipated to exhibit a robust growth in the long term on account of increasing investments in clinical, cell-based and regenerative medicine research. The technique is likely to gain from rising incidence of infectious and chronic diseases coupled with continuous expansion of the biotechnology and biopharmaceutical industries. The US is expected to dominate the global cell harvesting market and account for the leading share in the coming years. The regional market is dominated by the US due to increasing R&D investments and favorable government policies. The US FDA has approved cord blood-based blood-forming stem cells for use in the US. These cells along with stem cells derived from the bone marrow are widely used in medical transplant procedures for treatment of cancer along with diseases related to the immune system and blood. The US market is also bolstered by increasing healthcare expenditure in the country. While Europe is anticipated to secure the second-leading position, the Asia-Pacific region is estimated to exhibit the fastest growth rate. The regional market is driven by increasing R&D spending to develop new treatments, government policies favoring stem cell research, and public-private efforts to foster stem cell-based treatments. The Asia-Pacific market is likely to also gain from expansion of leading players across emerging economies in the region.

Research Methodology
This latest edition of the research study is conducted and published by Global Industry Analysts, Inc., in close collaboration with senior executives in the industry driving strategy, business development, marketing, sales, product management, technology and operations. The views, opinions and findings presented are based on validated engagements from a total executive pool size of 24228. Among this pool, 2181 direct interactions with domain experts were carried out via our proprietary market research platform, MarketGlass. Among the 482 unique participations, a total of 63 validated responses were received as part of this report's primary research outreach program. We are unique in the industry to provide our clients with the validated list executive engagements and the complete project data stack.

Key Competitors Covered in the Report -
PerkinElmer, Inc.
Terumo Corporation
GE Healthcare Life Sciences
Sartorius AG
Terumo BCT, Inc.
Tomtec, Inc.
Brandel
Connectorate AG
ADSTEC Corporation
Aspire Medical Innovation
Cox Scientific Ltd
CTIBiotech

Segments Covered in the Report -
Type (Manual, Automated)
Application (Peripheral Blood, Bone Marrow, Umbilical Cord, Adipose Tissue, Other Applications)
End-Use (Biotech & Biopharma Companies, Research Institutes, Other End-Uses)

Geographies Analyzed in the Report -
World
USA
Canada
Japan
China
Europe
France
Germany
Italy
UK
Rest of Europe
Asia-Pacific
Rest of World.

View Executive Engagement Dashboards, COVID Impact Questionnaires & Get Complimentary Access to Methodology & Full-Text Secondary Sources

For enquiries e-mail us at sales@strategyR.com .

For cutting edge analyst reviews on top industries, follow us on Twitter and connect with us on LinkedIn

About Global Industry Analysts, Inc.
Global Industry Analysts, Inc., (GIA) (www.strategyr.com) is the world`s only influencer driven AI powered market research company. Serving more than 41,000 clients from 36 countries, GIA is recognized for accurate forecasting of markets and industries for 33 years, offering the widest coverage of topics, geographic markets, competitive brands, and companies profiled.

Contact Us:
Zak Ali
Director, Corporate Communications
Global Industry Analysts, Inc.
Phone: 1-408-528-9966
Email: sales@StrategyR.com